Literature DB >> 1567367

Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.

O Yonekawa1, M Voskuilen, W Nieuwenhuizen.   

Abstract

In previous publications [e.g. Voskuilen, Vermond, Veeneman, Van Boom, Klasen, Zegers & Nieuwenhuizen (1987) J. Biol. Chem. 262, 5944-5946] we have shown that fibrin(ogen) chain fragment A alpha-(148-160) contains a site that contributes to the acceleration of Glu-plasminogen activation by tissue-type plasminogen activator (t-PA). In contrast with fibrin, this peptide, however, does not enhance the rate of mini-plasminogen activation. Therefore, possibly more stimulatory sites than A alpha-(148-160) are present in fibrin. In the present investigation we have localized a possible second type of stimulatory site in the fibrin(ogen) molecule. A whole CNBr digest of fibrinogen was applied to a Bio-Gel P-2 column run in water, pH 4. Two peaks with stimulatory activity were observed, one at the void volume and one between the void volume and the total volume. The former contained the previously described stimulating fragment FCB-2 [which comprises A alpha-(148-160)]; the latter had not been observed before and was characterized further. The stimulating material in the low-M(r) fraction of the Bio-Gel P-2 column was precipitated at pH 8.3 in a virtually pure form. It has a high tryptophan content, and an M(r) of 6500 as assessed by SDS/PAGE. On reduction, a main band of M(r) 2500 is seen, plus a weakly staining band of M(r) 4000. These properties plus the amino acid sequence data identify the fragment as FCB-5. FCB-5 consists of two chains, i.e. gamma-(311-336) and gamma-(337-379), linked by a single disulphide bond between Cys-gamma-326 and Cys-gamma-339. Both these chains and the disulphide bond appear to be essential for rate enhancement. FCB-5 enhances the activation rates of Glu-, mini- and micro-plasminogen, with all five kringles, only kringle V and without kringles respectively. FCB-5 binds t-PA, but none of the plasminogen forms binds to FCB-5. This indicates that the rate enhancements induced by FCB-5 are due to an effect on t-PA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567367      PMCID: PMC1131013          DOI: 10.1042/bj2830187

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

2.  Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations.

Authors:  P Wallén; B Wiman
Journal:  Biochim Biophys Acta       Date:  1970-10-20

3.  Amino acid sequence studies on the alpha chain of human fibrinogen. Characterization of 11 cyanogen bromide fragments.

Authors:  R F Doolittle; K G Cassman; B A Cottrell; S J Friezner; J T Hucko; T Takagi
Journal:  Biochemistry       Date:  1977-04-19       Impact factor: 3.162

4.  Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activator.

Authors:  J H Verheijen; W Nieuwenhuizen; D W Traas; G T Chang; E Hoegee
Journal:  Thromb Res       Date:  1983-10-01       Impact factor: 3.944

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.

Authors:  J H Verheijen; E Mullaart; G T Chang; C Kluft; G Wijngaards
Journal:  Thromb Haemost       Date:  1982-12-27       Impact factor: 5.249

7.  Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.

Authors:  W Nieuwenhuizen; A Vermond; M Voskuilen; D W Traas; J H Verheijen
Journal:  Biochim Biophys Acta       Date:  1983-10-17

8.  Purification and partial characterization of plasminogen activator from human uterine tissue.

Authors:  D C Rijken; G Wijngaards; M Zaal-de Jong; J Welbergen
Journal:  Biochim Biophys Acta       Date:  1979-09-29

9.  Binding of tissue-type plasminogen activator to fibrinogen fragments.

Authors:  P J Bosma; D C Rijken; W Nieuwenhuizen
Journal:  Eur J Biochem       Date:  1988-03-01

10.  Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.

Authors:  G Y Shi; H L Wu
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

View more
  7 in total

Review 1.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

2.  Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator.

Authors:  M Yamada; T Horiuchi; T Oribe; S Yamamoto; I Sugie; P A Gentry
Journal:  Vet Res Commun       Date:  1997-02       Impact factor: 2.459

3.  Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.

Authors:  R Bauer; S L Hansen; G Jones; E Suenson; S Thorsen; L Ogendal
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

4.  Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.

Authors:  J H Wu; S L Diamond
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

6.  Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.

Authors:  Katherine J Kearney; Nikoletta Pechlivani; Rhodri King; Christian Tiede; Fladia Phoenix; Ramsah Cheah; Fraser L Macrae; Katie J Simmons; Iain W Manfield; Kerrie A Smith; Benjamin E J Spurgeon; Khalid M Naseem; Robert A S Ariens; Michael J McPherson; Darren C Tomlinson; Ramzi A Ajjan
Journal:  Blood       Date:  2018-12-13       Impact factor: 22.113

7.  c.259A>C in the fibrinogen gene of alpha chain (FGA) is a fibrinogen with thrombotic phenotype.

Authors:  Ophira Salomon; Ortal Barel; Eran Eyal; Reut Shnerb Ganor; Yeroham Kleinbaum; Mordechai Shohat
Journal:  Appl Clin Genet       Date:  2019-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.